Marquette Intellectual Property Law Review

The Marquette Intellectual Property Law Review is a student-edited journal dedicated to encouraging critical, reflective thinking by scholars and practitioners regarding important cutting-edge issues in intellectual property law. The IPLR is one of four journals in the Marquette Law Scholarly Commons.

List of Papers (Total 303)

Copyrights Without Limits—The Undefeatable Right of Access Control Under §1201(A) of the Digital Millennium Copyright Act

none

Product Hopping 2.0: Getting the FDA To Yank Your Original License Beats Stacking Patents

none

Table of Contents

Table of Content

The End of the "Wild West" for Software Patents—Does the Patents Act 2013 Change New Zealand's Treatment of Software Patents From Permissive to Restrictive?

None

Notice and Supplemental Registration: Why the Copyright Office Must Update its Policies Surrounding Author Notice

None

A Presidential Remedy Under Administrative Control—Why Section 337(j) Should be Repealed

None

Can the PTO Find Its Way with Jesus?

None

Brands, Morality and Public Policy: Some Reflections on the Ban on Registration of Controversial Trademarks

None

The EU Trademark Reform Package—(Too) Bold a Step Ahead or Back to Status Quo?

None

The Intensifying National Interest in Patent Litigation

None

Table of Content

Likelihood of Destruction - Restructuring the Trademark Dilution by Blurring Factors in the Trademark Dilution Revision Act of 2006

None.

Functional Signs and Decanters of Wine: How Trade Dress Protection Unconstitutionally Extends Expired Design Patents

None.

Searching for an Out: Rojadirecta, MyVidster, and the Knowledge Components of the Information Location Tool Exemption of § 512(d)

None.

Indigenous Peoples

None.

Patent Club Convergence Among Nations

The article uncovers profound empirical and conceptual shortcomings concerning the "one-size-fits-all

Patent Markets: An Opportunity for Technology Diffusion and FRAND Licensing?

None.

One View of Compulsory Licensing: Comparative Perspectives From India and Canada

None.

Table of Contents

IP Policy Forum: Foreword From the Editors

IP Policy Forum: Intellectual Property Rights (IPR) In Collaborative Drug Development in the EU: Helping a European Public-Private Partnership Deliver - The Need for a Flexible Approach to IPR

None.

IP Policy Forum: Implications of Genomics Advances for Drug Discovery, Clinical Therapies, & Rare Disease Research

None.

IP Policy Forum: The Future of Clinical Trials: More Transparency and Pharmacogenomics

None.

IP Policy Forum: Repurposing & Collaborative Drug Development for Rare Diseases

None.